Factor V mutation illuminates the dominant anticoagulant role and importance of an unidentified platelet modifier

J Thromb Haemost. 2021 May;19(5):1168-1170. doi: 10.1111/jth.15273.

Authors

Josefin Ahnström¹, Gary E Gilbert^{2

3

4}

Affiliations

¹ Centre for Haematology, Imperial College London, London, UK.
² Department of Research, VA Boston Healthcare System, Boston, Massachusetts, USA.
³ Department of Medicine, VA Boston Healthcare System, Boston, Massachusetts, USA.
⁴ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

PMID: 33880872
DOI: 10.1111/jth.15273

No abstract available

MeSH terms

Anticoagulants*
Blood Coagulation / genetics
Blood Platelets
Factor V* / genetics
Humans
Mutation

Substances

Anticoagulants
Factor V

Grants and funding

PG/20/13/34994/BHF_/British Heart Foundation/United Kingdom